Class IITerminatedD-1058-2013
Drug recall · September 25, 2013
Bevacizumab 1.25 mg/0.05 mL PF recall
Why: Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bevacizumab 1.25 mg/0.05 mL PF, Avella Specialty Pharmacy, Phoenix, AZ, 85085, 877-782-7684
- Lots / codes
12-20130508@179, Exp 11/3/2013
- Quantity
- 750 units
- Company
- Avella of Deer Valley, Inc., Phoenix, AZ
- Distribution
- Nationwide and Puerto Rico
- Initiated
- September 9, 2013 · Voluntary: Firm initiated
- Classified
- September 16, 2013
- Reported
- September 25, 2013
- Ended
- October 17, 2013
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.